Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Pfizer To Cease output In Sandwich

September 17, 2007 | A version of this story appeared in Volume 85, Issue 38

Pfizer will end all active pharmaceutical ingredient manufacturing at its site in Sandwich, England. The decision, which will result in the loss of about 420 jobs over the next two years, follows the 2005 announcement of a manufacturing scale-back at the site that affected some 400 jobs. Pfizer says it remains committed to conducting R&D in Sandwich, which earlier this year was identified as one of the firm's four key research locations.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.